Newport Biotech Consultants

Dr. John Morrow and Dr. Kaspar Hoebe discuss research at Cincinnati Children's Hospital

Dr. Chris Mayhew and technician Amy Pitstick of Cincinnati Children's Hospital

John Morrow and Matt Gaevert discuss Kiyatec's 3D culture technology

Discussing climate change at University of Cincinnati

Morrow and Mayhew consider stem cell technology at Cincinnati Children's

A visit to Biologic Covington KY

Morrow discussing Bexion technology with Dr. Neil Chaudhary

Discussing protein characterization assays at Bexion

Morrow meets with Paul Davis, CEO Quanta Biodesign

with Steve King, CEO Peregrine Pharmaceuticals

with Cheng Liu, CEO Eureka Pharma

Sartorius Conference, Gottingen, Germany with Bettina Berendsen, VP sales

Performance exceeding expectations.

Newport Biotechnology Consultants serves the life sciences industry providing research, writing, business planning and emergency management solutions.  Founder Dr. K. John Morrow Jr. (President/CEO) draws upon academic and industrial experience to cover new developments and technologies in antibody therapeutics and related areas of biotechnology. With an extensive list of publications in trade and peer-reviewed journals, we are prepared to evaluate business plans, prepare technical reports and develop advertising literature. To download some of my latest publications go to "Who We Are" page.


A range of quality services

  • Writing expertise
    • life sciences industry
    • specialization in molecular immunology
  • Coverage of new developments and technologies
  • Emergency management
  • Bio-Safety Consulting
  • Business plan evaluation.
  • Translation, Interpretation   (English/Italian) 
  • Recently published: "Cancer, Autism and Their Epigenetic Roots" McFarland Publishers

View all Services

Recent Blog Entries

Shoddy drug research goes both ways

October 17, 2016

In the last few years there have been a striking number of claims of irreproducible pre-clinical pharma research. One of the most devastating was a 2012 report from Amgen researchers who were unable to reproduce the results of...

Read More